This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Pathological features

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Macroscopically in Crohn's disease there may be a swollen, reddened and rubbery bowel with:

  • skip lesions - discontinuous sites of pathology along the gastrointestinal tract
  • cobblestone ulceration; a result of apthous ulceration progressing to oedema and nodular thickening
  • lead pipe thickening - thickened, stiff bowel
  • narrowed lumen
  • strictures
  • 'rose-thorn' narrow-mouthed ulcers which lead to fistulae
  • fistulae, often between adherent bowel and/or bladder, vagina, other abdominal organs or the abdominal wall
  • mesenteric fat covering serosa (1)
  • enlarged mesenteric nodes

Microscopically, there is:

  • non-caseating granulomas - not always present
  • transmural inflammation and lymphocyte infiltration (1)

Crohn's disease may involve any part of the bowel from the mouth to the anus:

  • the terminal ileum is involved in nearly 50% of cases
  • jejunoileitis is also seen, but most ileal inflammation usually ends abruptly at the ileocaecal junction
  • caecal and right colonic involvement is more common than lesions in the stomach and duodenum

Reference:


Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.